Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


25 11, 2015

Financial aid: Takeda wants to help. Lets work together

Tags: , , , , , , , |6 Comments

I had an opportunity to interview several Takeda Pharmaceutical team members about the company's new oral, proteasome inhibitor, Ninlaro (ixazomib), yesterday afternoon. I have heard from dozens of patients who find themselves stuck paying thousands of dollars out-of-pocket for two established oral chemotherapy drugs, Revlimid and Pomalyst. I'm concerned that the same obstacles might face

29 06, 2015

Myeloma News Update

Tags: , , |2 Comments

So much happened today--and it isn't over.  I'm heading to the BMT unit for yet another neupogen and Mozobil injection in a few moments. I'll post a medical update tomorrow morning.  In the meantime, there's been some myeloma related news.  The European Medicines Agency (EMA) is expected to approve panobinostat for use in Europe in

13 06, 2015

It’s official: panobinostat works!

Tags: , , |2 Comments

Novartis released final data from its PANORAMA Phase 3 panobinostat (Farydak) trial in advance of meetings (similar to ASCO or ASH) in Europe later this month: Novartis data at EHA show increased PFS benefit of Farydak® in new subgroup of patients with previously treated multiple myeloma - Panobinostat combination more than doubled median PFS benefit